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Objectives: There are few studies in Spain about outcomes at six months in 
terms of health-related quality of life (HRQoL) in patients hospitalized by heart 
failure (HF). The objective of the study was to evaluate changes in HRQoL from 
baseline to six months post discharge in patients with HF through three ques-
tionnaires, SF-12, EQ-5D-3L and Minnesota Living with Heart Failure questionnaire 
(MLHFQ). MethOds: This is a prospective study with 976 patients admitted by HF. 
Patients completed questionnaires during their hospitalization and at six months. 
The MLHFQ is a specific instrument which has 21 items with an overall scale, physi-
cal (8 items) and emotional (5 items) subscales. MLHFQ items are scoring from 0 
(best) to 5 (worse). Total score ranges from 0 to 105, physical domain from 0 to 40 
and emotional from 0 to 25. SF-12 has two dimensions, Physical Summary Score 
(PCS) and Mental Summary Score (MSC) which scores range from 0 (worst) to 100 
(best). EQ-5D has been measured according to the Spanish tariffs by time trade-off 
and the visual analogic scale. We used general linear model to study gains in each 
dimension adjusted by baseline score, age, gender and readmissions in the previous 
6 months. Results: Mean age was 76.0 (SD= 10.4), there were a 53.3% of men and 
33.1% of readmissions in the previous six months. Regarding all questionnaires and 
dimensions, baseline status influence in gains, the worse the baseline the more 
the gains. Likewise men have greater gains and patients readmitted lower in all 
domains. Age has an influence in all domains but emotional dimension of MLHFQ 
and MSC of SF-12. cOnclusiOns: Adjusted by baseline score and readmissions, 
men have greater improvements in all domains of MLHFQ, SF-12 and EQ-5D. On the 
other hand, the younger the patients the higher the improvement is, however age 
does not have any influence in psychological domains.
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Objectives: Warfarin anticoagulation is monitored using international normal-
ized ratio (INR); specified with the narrow/wide 2.0–3.0/1.9–3.5 therapeutic target 
range, and converted to time in the therapeutic range (TTR, total percentage of 
time the INR reading is within the INR therapeutic range). We explored the impact 
of I) INR monitoring and II) TTR on patients’ quality of life (QoL). MethOds: A 
total of 647 unselected patients visiting 3 health centres in Pirkanmaa district 
(31.01–11.02.2011), Finland participated to prospective study. To assess INR moni-
toring or TTR and QoL, Beta regressions were applied in Stata and EQ-5D-3L-based 
QoL (Smithson&Verkuilen transformation) 3 months after the baseline visit was 
the dependent variable. The covariates were CHADS2(congestive heart failure, 
hypertension, age> 75, diabetes mellitus, stroke) score, other comorbidities, 
baseline QoL, time difference (days) between dependent variable measurement 
and mean TTR time point (subgroup model), and INR monitoring (yes/no in total 
population) or TTR % (subgroup model). Results: A total of 28 patients (46.43% 
male; means: age 73.21 years, CHADS2-score 2.39, other comorbidities amount 
1.71, baseline QoL 0.8334, INR tests 4.21, 66.31%/82.86% INR measurements on 
the narrow/wide range) had INR measurements (“warfarinization group”) during 
the 3 months follow-up. 27 patients had calculable TTR (Rosendaal method) that 
was 69.29%/86.66% on the narrow/wide range. In the beta regression (N 393, +1 
marginal change), CHADS2-score (-0.021), other comorbidities amount (-0.030), 
baseline QoL (+0.350), and INR monitoring (p= 0.299, -0.042, SE 0.044) predicted QoL. 
The mean adjusted QoL with/without INR monitoring in the warfarinization-like 
group was 0.794/0.836. In subgroup Beta regression including only warfariniza-
tion patients, higher TTR levels predicted lower QoL (p< 0.050, +1 %-unit marginal 
change -0.006 [SE 0.007]; discrete change -0.284 in the wide range from 35.3% to 
100.0%). cOnclusiOns: INR monitoring may predict QoL loss and, surprisingly, 
higher TTR predicts lower QoL. Larger studies are needed to confirm the potential 
relationship between TTR and QoL.
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Objectives: Assess health-related quality of life (HRQoL) of patients with 
CAD. MethOds: The main observational study cohort enrolled consecutive patients 
admitted in ICU at tertiary care hospital and diagnosed with CAD. Demographic 
information, risk factors for CAD, and angiographic findings were collected. EQ-5D 
was administered at 1-year follow-up. EQ-5D levels were dichotomized: ‘no prob-
lems’ (level 1), ‘any problem’ (levels 2 and 3). Linear stepwise regression was used 
to assess predictors of all 5 health states (mobility, self-care, usual activities, pain/
discomfort, anxiety/depression). The independent variables studied include age, 
hypertension, diabetes, CHF, gender, prior MI, final diagnosis, MI type, and final 
treatment. Respondents reporting problems EQ-5D dimensions were stratified by 
presence of diabetes and compared. Results: Of 960 CAD patients enrolled for the 
main cohort study (30% diabetic), 306 (male, 230; diabetics, 64) responded HRQoL 
questionnaire at 1-year. On liner regression, presence of diabetes was independent 
predictor of 4/5 EQ-5D HRQoL dimensions: mobility (p= 0.019), problems performing 
usual activities (p= 0.041), pain/discomfort (p< 0.001); anxiety/depression (p= 0.001). 
At 1-year, mean EQ-5D utility index score and VAS score were significantly lower 
for diabetes vs non-diabetics (0.76±0.13 vs. 0.83±0.15, p= 0.0003 and 67.8 ± 8.8 vs. 
73.6±5.4, p= 0.0001, respectively) with more problems with performing usual activi-
ties (56.3% vs. 41.3%, p= 0.04), pain or discomfort (51.6% vs. 17.8%, p= 0.0001) as 
well as anxiety/depression (32.8% vs 14.9%, p= 0.002). cOnclusiOns: Among CAD 
This was especially evident for SPC patients in the 40~64 year age group (0.71 for SPC, 
0.69 for FC) and patients with two or more comorbidities (0.73 for SPC, 0.69 for FC) (P= 
0.0011). However, no statistical significance was observed for the difference both in 
persistence and the BP change between the two groups. cOnclusiOns: Our study 
suggests that compliance tends to be improved by the use of SPC compared with 
FC. Unlike the previous western studies, it was hard to find a significant increase in 
persistence or BP change with SPC therapy in this study.
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Objectives: Telemedical systems (TMS) and data management for implantable 
cardioverter-defibrillators (ICD) promise to reduce costs and optimize patient 
care. Depressive symptoms are common among patients with an ICD and the 
health related quality of life (HRQoL) is affected by the underlying disease and the 
implanted device, respectively. TMS might improve the HRQoL of patients and ICDs 
acceptance due to closer monitoring and, thereby, an increased level of perceived 
safety. In this RCT, changes in the level of depression, HRQoL and ICD-acceptance 
over a period of six months after ICD-implantation were investigated. MethOds: 
A total of 161 patients (80.7% male; age: 64,1±14,6; 82% with coronary disease, 11% 
with DCM) with an ICD were randomized at the day of implantation into interven-
tion (n= 82) or control group (n= 79). The intervention group was equipped with a 
telemonitoring-system that transferred ICD-data from the patients’ home to the 
medical practitioner. The control group received regular care. Patients were asked to 
fill out three questionnaires (the generic EQ-5D, the depression specific HADS and 
the device specific FPAS); the follow-up period was six month, with postal surveys 
on a monthly basis. Results: Nine patients dropped out before survey comple-
tion. A total of 140 patients filled out at least two sets of questionnaires and were 
included in the analyses. After six months the mean improvement in the HRQoL 
(EQ-5D-Index) in the telemonitoring group was 10.7 points compared to baseline 
(p= .006) while the mean change in HRQoL in the control group was 5.5 (p= .138). FPAS 
and HADS-D showed small but non-significant advantage for the telemonitoring 
group. cOnclusiOns: Preliminary results suggest that TMS have the ability to 
improve HRQoL of patients with ICDs. Results on effects towards depression and 
anxiety and enhancement of ICDs acceptance are also promising. Since ICDs are 
used in chronic diseases a longer follow-up period seems to be required to validate 
the effects.
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Objectives: To assess convergent and divergent validity of a new questionnaire 
(SAFUCA) developed to measure satisfaction with medical care in patients with 
non valvular atrial fibrillation. MethOds: The 25-item reduced version instru-
ment was administered along with the Treatment Satisfaction Questionnaire for 
Medication (TSQM), and 5 Visual Analog Scales (VAS) measuring: Health Related 
Quality of Life (HRQoL), Effectiveness and Overall Satisfaction assessed by the 
patient; and Effectiveness and Tolerability assessed by the clinician. A convenience 
sample of 230 patients recruited at 7 health centers (5 hospitals and 2 primary care 
centers) in Spain was used. Second Order Exploratory Factor Analysis (SO-EFA) and 
correlation with VAS scales were computed. Results: SAFUCA dimensions cor-
related (p< 0.001) higher with corresponding TSQM dimensions (e.g.: Effectiveness 
r= 0.450, Convenience r= 0.457, Undesired Effects r= -0.340, Overall satisfaction 
r= 0.651), while SO-EFA made evident differences regarding the assessment of 
satisfaction with INR controls, interference in QoL and Medical Care. Correlation 
pattern between VAS scores was significantly different between primary care cent-
ers and hospitals, with a higher correlation between patient and clinician scores 
observed in primary care (e.g.: Effectiveness rPC= 0.430 vs. rH= 0.057). Similarly, 
correlation patterns between VAS concurrent scales and SAFUCA dimensions 
differed between center types. While high correlations between Effectiveness 
dimension and patient satisfaction VAS were observed in both cases (rPC= 0.521 
vs. rH= 0.516), correlation of Tolerability with Undesired Effects differed between 
centers (rPC= -0.474 vs. rH= -0.085). cOnclusiOns: The 25-item questionnaire 
exhibits good convergent and divergent validity values. Differences between 
types of health care centers in correlation patterns were meaningful and worth 
of further research.
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